[artículo] 
inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 672-677

Título :	Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults
Tipo de documento:	texto impreso
Autores:	Eric J. Lenze, Autor ; Alison M. Goate, Autor ; Petra Nowotny, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 672-677
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Geriatría, Trastornos de ansiedad, Genética, ISRS
Resumen:	Generalized anxiety disorder (GAD) is common in older adults and can be treated with selective serotonin reuptake inhibitors (SSRIs). Genetic variation in the serotonin transporter gene promoter region is posited to be associated with SSRI efficacy: 2 polymorphisms (5-HTTLPR S/L and rs25531 g/a) form a haplotype with the La combination having higher transcription activity than other haplotypes.
Link:	./index.php?lvl=notice_display&id=29414

[artículo] Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults [texto impreso] / Eric J. Lenze, Autor ; Alison M. Goate, Autor ; Petra Nowotny, Autor . - 2022 . - pp. 672-677.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 672-677

Palabras clave:	Geriatría, Trastornos de ansiedad, Genética, ISRS
Resumen:	Generalized anxiety disorder (GAD) is common in older adults and can be treated with selective serotonin reuptake inhibitors (SSRIs). Genetic variation in the serotonin transporter gene promoter region is posited to be associated with SSRI efficacy: 2 polymorphisms (5-HTTLPR S/L and rs25531 g/a) form a haplotype with the La combination having higher transcription activity than other haplotypes.
Link:	./index.php?lvl=notice_display&id=29414